{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T23:31:31Z","timestamp":1777851091593,"version":"3.51.4"},"reference-count":57,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Generic Medicines"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>Generic Drugs are copies of small chemical drugs identical to their reference drug by dose, form, safety, strength, mode of administration, quality, performance, and intended purpose. They have been on the market for a long time and have abbreviated pathways to be approved. Their development is more simple and more affordable than their reference counterpart, which makes them widely used by patients. More recently, biosimilars were introduced to the market with strict regulations. They are highly similar to large, complex molecules, known as biological drugs, in terms of quality characteristics, biological activity, safety, and efficacy. Their development is complex and expensive, where clinical trials are necessary. Even though generic drugs and biosimilars are both copies of a reference drug, they differ in many aspects. Misconceptions or misinformation among healthcare stakeholders could have limited their use. Therefore, this short review aims to compare generic drugs and biosimilars in terms of characteristics, development, regulation, and interchangeability with brand drugs. Findings from this report can help clarify misconceptions and promote their use.<\/jats:p>","DOI":"10.1177\/17411343231157309","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T09:21:37Z","timestamp":1676625697000},"page":"124-129","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of the differences between generic and biosimilar drugs: A brief literature review"],"prefix":"10.1177","volume":"19","author":[{"given":"Roudy","family":"Sayah","sequence":"first","affiliation":[{"name":"Clinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Lebanese University, Hadat, Lebanon"}]},{"given":"Sanaa","family":"Awada","sequence":"additional","affiliation":[{"name":"Clinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Lebanese University, Hadat, Lebanon"}]},{"given":"Lina","family":"Ismaiil","sequence":"additional","affiliation":[{"name":"Clinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Lebanese University, Hadat, Lebanon"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0964-9722","authenticated-orcid":false,"given":"Georges","family":"Hatem","sequence":"additional","affiliation":[{"name":"Clinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Lebanese University, Hadat, Lebanon"},{"name":"Faculty of Medicine, University of Porto, Porto, Portugal"}]}],"member":"179","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"bibr1-17411343231157309","doi-asserted-by":"crossref","unstructured":"Vincent Rajkumar S. The high cost of prescription drugs: causes and solutions. Berlin, Germany: Nature Publishing Group, 2020, pp. 1\u20135.","DOI":"10.1038\/s41408-020-0338-x"},{"key":"bibr2-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5444"},{"key":"bibr3-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1111\/1468-0009.12279"},{"key":"bibr4-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1711899"},{"key":"bibr5-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204146"},{"key":"bibr6-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-019-0177-y"},{"key":"bibr7-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1180"},{"key":"bibr8-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3652-2"},{"key":"bibr9-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1177\/0951484817752630"},{"key":"bibr10-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1108\/IJPHM-12-2018-0064"},{"key":"bibr11-17411343231157309","doi-asserted-by":"publisher","DOI":"10.5530\/ijopp.11.2.19"},{"issue":"1","key":"bibr12-17411343231157309","first-page":"4","volume":"5","author":"Hatem G","year":"2022","journal-title":"BAU J"},{"key":"bibr13-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.8561"},{"key":"bibr14-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1002\/hpm.3480"},{"key":"bibr15-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1177\/17411343221076963"},{"key":"bibr16-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2017.08.001"},{"key":"bibr17-17411343231157309","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1940_17"},{"key":"bibr18-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3796"},{"key":"bibr19-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.3588"},{"key":"bibr20-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1163\/9789004418233_021"},{"key":"bibr21-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb05435.x"},{"issue":"8","key":"bibr22-17411343231157309","first-page":"420","volume":"36","author":"Janssen WF","year":"1981","journal-title":"Food Drug Cosmet Law J"},{"key":"bibr23-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1353\/book.72111"},{"key":"bibr24-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0126"},{"key":"bibr25-17411343231157309","doi-asserted-by":"publisher","DOI":"10.5912\/jcb562"},{"key":"bibr26-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1159\/000455387"},{"key":"bibr27-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1007\/s12254-013-0094-8"},{"key":"bibr28-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2016.1272308"},{"key":"bibr29-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.151"},{"key":"bibr30-17411343231157309","doi-asserted-by":"publisher","DOI":"10.5639\/gabij.2014.0304.039"},{"key":"bibr31-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0717-1"},{"key":"bibr32-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1517\/14712591003662615"},{"key":"bibr33-17411343231157309","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_150_21"},{"key":"bibr34-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2017.026062"},{"key":"bibr35-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.5202"},{"key":"bibr36-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2008.00942.x"},{"issue":"1","key":"bibr37-17411343231157309","first-page":"11","volume":"11","author":"Crommelin D","year":"2005","journal-title":"Eur J Hosp Pharm Sci"},{"key":"bibr38-17411343231157309","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200721060-00003"},{"key":"bibr39-17411343231157309","first-page":"0851","volume":"4","author":"Bhupinder S","year":"2012","journal-title":"J Bioequiv Availab"},{"key":"bibr40-17411343231157309","doi-asserted-by":"publisher","DOI":"10.4103\/2230-973X.104392"},{"key":"bibr41-17411343231157309","doi-asserted-by":"publisher","DOI":"10.4103\/2230-973X.187350"},{"key":"bibr42-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1002\/wics.1310"},{"key":"bibr43-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2274"},{"key":"bibr44-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110116"},{"key":"bibr45-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.06.039"},{"key":"bibr46-17411343231157309","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0553"},{"key":"bibr47-17411343231157309","doi-asserted-by":"crossref","unstructured":"Olech E. Biosimilars: rationale and current regulatory landscape. In: Seminars in arthritis and rheumatism, Amsterdam, Netherlands, 2016. Elsevier, pp. S1\u2013S10.","DOI":"10.1016\/j.semarthrit.2016.01.001"},{"key":"bibr48-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-012-9406-x"},{"key":"bibr49-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01610-1"},{"key":"bibr50-17411343231157309","volume-title":"Orange book: approved drug products with therapeutic equivalence evaluations","author":"Home F","year":"2013"},{"key":"bibr51-17411343231157309","doi-asserted-by":"publisher","DOI":"10.4155\/ppa.14.58"},{"issue":"7","key":"bibr52-17411343231157309","first-page":"532","volume":"21","author":"Li E","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"bibr53-17411343231157309","unstructured":"Thimmaraju PK, Rakshambikai R, Farista R et al. Legislations on biosimilar interchangeability in the US and EU - developments far from visibility. Generics and Biosimilars Initiative. 2015. [accessed on November 3, 2022]. Available from: http:\/\/www.gabionline.net\/Sponsored-Articles\/Legislations-on-biosimilar-interchangeability-in-the-US-and-EU-developments-far-from-visibility."},{"key":"bibr54-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2438"},{"key":"bibr55-17411343231157309","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-017-0210-0"},{"issue":"3","key":"bibr56-17411343231157309","first-page":"266","volume":"23","author":"Rubinstein E","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"bibr57-17411343231157309","first-page":"33","volume":"28","author":"Al-Jazairi AS","year":"2008","journal-title":"Ann Saudi Med"}],"container-title":["Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17411343231157309","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17411343231157309","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17411343231157309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:16:28Z","timestamp":1777500988000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17411343231157309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1177\/17411343231157309"],"URL":"https:\/\/doi.org\/10.1177\/17411343231157309","relation":{},"ISSN":["1741-1343","1741-7090"],"issn-type":[{"value":"1741-1343","type":"print"},{"value":"1741-7090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]}}}